Cancer Gene Therapy - Table of Contents alert Volume 22 Issue 3

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 22, Issue 3 (April 2015) In this issue Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Epigenome Roadmap Nature Publishing Group presents an online portal - the Epigenome Roadmap - which collects key research papers from The NIH Roadmap Epigenomics Program, complemented by thematical 'threads' to help the readers mine the wealth of available information. Access the Epigenome Roadmap for FREE at:  nature.com/epigenomeroadmap Produced with exclusive support from  Illumina Original Articles Top MMP-9 is increased in the pathogenesis of gastric cancer by the mediation of HER2 Y-Q Shan, R-C Ying, C-H Zhou, A-K Zhu, J Ye, W Zhu, T-F Ju and H-C Jin Cancer Gene Ther 2015 22: 101-107; advance online publication, January 30, 2015; 10.1038/cgt.2014.61 Abstract | Full Text miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells Z Zhao, L Zhang, Q Yao and Z Tao Cancer Gene Ther 2015 22: 108-114; advance online publication, February 27, 2015; 10.1038/cgt.2014.73 Abstract | Full Text Silencing stathmin-modulating efficiency of chemotherapy for esophageal squamous cell cancer with paclitaxel W Feng, X Xiaoyan, Y Xuan, L Xiangke, Y Zichang, Z Ran, W Liuxing and F Qingxia Cancer Gene Ther 2015 22: 115-121; advance online publication, January 9, 2015; 10.1038/cgt.2014.74 Abstract | Full Text MicroRNA let-7b suppresses human gastric cancer malignancy by targeting ING1 X Han, Y Chen, N Yao, H Liu and Z Wang Cancer Gene Ther 2015 22: 122-129; advance online publication, January 23, 2015; 10.1038/cgt.2014.75 Abstract | Full Text Tomato thymidine kinase-based suicide gene therapy for malignant glioma—an alternative for Herpes Simplex virus-1 thymidine kinase H Stedt, H Samaranayake, J Kurkipuro, G Wirth, L S Christiansen, T Vuorio, A-M Määttä, J Piškur and S Ylä-Herttuala Cancer Gene Ther 2015 22: 130-137; advance online publication, January 23, 2015; 10.1038/cgt.2014.76 Abstract | Full Text Long noncoding RNA PEG10 regulates proliferation and invasion of esophageal cancer cells W Zang, T Wang, J Huang, M Li, Y Wang, Y Du, X Chen and G Zhao Cancer Gene Ther 2015 22: 138-144; advance online publication, January 16, 2015; 10.1038/cgt.2014.77 Abstract | Full Text HER-2-induced PI3K signaling pathway was involved in the pathogenesis of gastric cancer Y F Fu, R Gui and J Liu Cancer Gene Ther 2015 22: 145-153; advance online publication, January 23, 2015; 10.1038/cgt.2014.80 Abstract | Full Text The addition of recombinant vaccinia HER2/neu to oncolytic vaccinia-GMCSF given into the tumor microenvironment overcomes MDSC-mediated immune escape and systemic anergy C R de Vries, C E Monken and E C Lattime Cancer Gene Ther 2015 22: 154-162; advance online publication, January 30, 2015; 10.1038/cgt.2015.2 Abstract | Full Text Ultrasound as a method to enhance antitumor ability of oncolytic herpes simplex virus for head and neck cancer S Okunaga, A Takasu, N Meshii, T Imai, M Hamada, S Iwai and Y Yura Cancer Gene Ther 2015 22: 163-168; advance online publication, February 6, 2015; 10.1038/cgt.2015.3 Abstract | Full Text Advertisement Reach the widest possible audience in the shortest possible time Scientific Reports is the home for rapidly published, highly visible open access research. Multi-disciplinary in scope, we're open to all, publishing sound original research papers across the sciences without barriers to access.  What can we do for your research?   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.